Wardex Pharmaceuticals Private Limited, a active private limited company, was established on 18 December 1946 in Madras-29, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51397TN1946PTC005759. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹4.20 M.
Formerly known as Ward Blenkinsop & Co. (India) Private Limited, Ward Blenkinsop & Co. (India) Limited. It upholds a compliant status. Employing 102 professional, Its leadership includes Errol James Desouza (Additional Director), Jagdish Purushottamdas Mehta (Director), Syed Asif Raza Rizvi (Director). Past directors included Manik Lal Saha, Noel Christopher Amanna, Ugra Sen Singh. It holds ₹3.00 M open charges and ₹1.64 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at 55,Nelson Manicka Mudaliarroad,Aminjikarai, Madras-29, Madras-29, Tamil Nadu, 600029.
U51397TN1946PTC005759
005759
18 December 1946
₹1.00 Cr
₹4.20 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Wardex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Errol James Desouza | Additional Director | 28 Jan 2025 | Current |
| Jagdish Purushottamdas Mehta | Director | 19 Mar 2014 | Current |
| Syed Asif Raza Rizvi | Director | 26 Feb 2021 | Current |
| Vitalapuram Rajangam Krishna Subramanian | Director | 01 Feb 1999 | Current |
| Venkatraman Subramaniam | Director | 27 Jan 2018 | Current |
| Pascal Postel | Director | 31 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Apr 2014 | Past |
| Pramod Abcsdd | Director | 23 Feb 2021 | Past |
| Pramod Abcsdd | Director | 29 May 2017 | Past |
| Pramod Abcsdd | Director | 02 May 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 26 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wardex Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.49% increase. The company also saw a substantial improvement in profitability, with a 38.87% increase in profit. The company's net worth moved up by a moderate rise of 1.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Wardex Pharmaceuticals had a public holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹16,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 1982 | Catholic Syrian Bank Ltd. | ₹3.00 M | Open |
| 26 Sep 2014 | Bnp Paribas | ₹7.50 M | Satisfied |
| 20 Sep 1996 | Banque Nationale De Paris | ₹6.90 M | Satisfied |
| 10 Nov 1978 | Banque Natinale De Paris | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Wardex Pharmaceuticals has a workforce of 102 employees as of Aug 30, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Wardex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wardex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 26 Sep 2014 via Charge ID 10524177 with Bnp Paribas was fully satisfied on 22 Apr 2025. was recorded as a recent event.
The activity A charge registered on 20 Sep 1996 via Charge ID 90300649 with Banque Nationale De Paris was fully satisfied on 22 Apr 2025. was completed.
Progress on A charge registered on 10 Nov 1978 via Charge ID 90299117 with Banque Natinale De Paris was fully satisfied on 22 Apr 2025. was documented.
Errol James Desouza was appointed as a Additional Director was appointed as a Additional Director on 28 Jan 2025 & has been associated with this company since 10 months 1 day . was recorded as a recent event.
Progress on Wardex Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
Wardex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The CIN of Wardex Pharmaceuticals Private Limited is U51397TN1946PTC005759.
Wardex Pharmaceuticals Private Limited is headquartered at 55,Nelson Manicka Mudaliarroad,Aminjikarai, Madras-29, Madras-29, Tamil Nadu, 600029.
Wardex Pharmaceuticals Private Limited was incorporated on 18 December 1946.
The current directors of Wardex Pharmaceuticals Private Limited are
The primary industry of Wardex Pharmaceuticals Private Limited is Manufacturing.
Wardex Pharmaceuticals Private Limited is unlisted.
The authorized capital of Wardex Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹4.20 M.
The compliance status of Wardex Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX